CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to evaluate the efficacy and safety of GX-I7 in combination with bevacizumab in subjects with recurrent glioblastoma...
Phase 2
Seoul, Korea, Republic of
evaluate the maximum tolerated dose, safety and efficacy of BEY1107 in combination with Temozolomide in Patients with Recurrent or Progressive Glioblastoma...
Phase 1
Seoul, Korea, Republic of
(TNBC), ovarian cancer, gastric cancer, colorectal cancer (CRC), glioblastoma (GBM), biliary tract cancers (BTC), or pancreatic can...
Phase 2
Seoul, Korea, Republic of and 87 other locations
Researchers are looking for a better way to treat people with solid tumors. Before a treatment can be approved for people to take, researchers do cli...
Phase 2
Seoul, Korea, Republic of and 33 other locations
progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of i...
Phase 3
Seoul, Korea, Republic of and 18 other locations
receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma multiforme (GBM...
Phase 1, Phase 2
Seoul, Korea, Republic of and 25 other locations
Clinical trials
Research sites
Resources
Legal